AbbVie Looks To Umoja To Partner On In Vivo CAR-Ts
Umoja Also Signs Deal With IASO Bio
Umoja’s technology is meant to enable development of CAR-Ts that could potentially overcome the challenges associated with autologous cell therapies, especially related to manufacturing.
